Inactive Instrument

KV Pharmaceutical Co. CL 'B' Share Price Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

KV Pharmaceutical Co. CL 'B' : KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	16/13/16	PR
KV Pharmaceutical Co. CL 'B' : Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing	24/13/24	PR
KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Receives Court Approval of Hologic Settlement	28/12/28	PR
KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization	13/12/13	PR

Sector